FDA
-
-
-
-
-
-
-
Lantern Pharma closes $9.25 million registered direct offering
-
-
-
-
-
-
-
Lantern Pharma’s predictBBB.ai Evolves Into a Real-Time Large Quantitative Model (LQM) for Precision Molecular Intelligence — Comprehensive Small Molecule Characterization & Development Analyt
-
-
-
-
-
-
-
Lantern Pharma Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
-
-
-
-
-
-
-
Lantern Pharma establishes AI center in India to expand RADR platform
-
-
-
-
-
-
-
Lantern Pharma reports complete response in DLBCL patient after CAR-T failure
-
-
-
-
-
-
-
RedChip to Host Exclusive Investor Webinar Featuring Lantern Pharma on August 26
-
-
-
-
-
-
-
Lantern Pharma Completes Targeted Enrollment for Lung Cancer Phase 2 Harmonic™ Clinical Trial in Japan for LP-300
-
323,147 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

